These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25189433)

  • 1. Dietary phosphorus intake and distribution in Chinese peritoneal dialysis patients with and without hyperphosphatemia.
    Jiang N; Fang W; Yang X; Zhang L; Yuan J; Lin A; Ni Z; Qian J
    Clin Exp Nephrol; 2015 Aug; 19(4):694-700. PubMed ID: 25189433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving diet recipe and cooking methods attenuates hyperphosphatemia in patients undergoing peritoneal dialysis.
    Jiang N; Fang W; Gu AP; Yuan JZ; Yang XX; Lin AW; Ni ZH; Qian JQ
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):846-852. PubMed ID: 26141941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
    Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
    Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorus control in peritoneal dialysis patients.
    Yavuz A; Ersoy FF; Passadakis PS; Tam P; Evaggelos DM; Katopodis KP; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis GJ; Dombros NA; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis CP; Yavuz M; Tsakiris DJ; Dimitriades AC; Yilmaz ME; Gültekin M; Süleymanlar G; Oreopoulos DG
    Kidney Int Suppl; 2008 Apr; (108):S152-8. PubMed ID: 18379539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients.
    Imtiaz R; Hawken S; McCormick BB; Leung S; Hiremath S; Zimmerman DL
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.
    Sullivan C; Sayre SS; Leon JB; Machekano R; Love TE; Porter D; Marbury M; Sehgal AR
    JAMA; 2009 Feb; 301(6):629-35. PubMed ID: 19211470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of dietary protein on serum phosphorous levels in peritoneal dialysis patients with different initial transport function.
    Wang XP; Ma Y; Lv J; Liang Y; Jin L; Lu WH; Liang CN; Qian B; Li Z
    Ren Fail; 2022 Dec; 44(1):2085-2092. PubMed ID: 36426736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial Factors That Create Barriers to Managing Serum Phosphorus Levels in Pediatric Dialysis Patients: A Retrospective Analysis.
    Taylor JM; Oladitan L; Degnan A; Henderson S; Dai H; Warady BA
    J Ren Nutr; 2016 Jul; 26(4):270-5. PubMed ID: 26993357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis.
    Bernardo AP; Contesse SA; Bajo MA; Rodrigues A; Del Peso G; Ossorio M; Cabrita A; Selgas R
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):591-7. PubMed ID: 21115631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacing Phosphorus-Containing Food Additives With Foods Without Additives Reduces Phosphatemia in End-Stage Renal Disease Patients: A Randomized Clinical Trial.
    de Fornasari ML; Dos Santos Sens YA
    J Ren Nutr; 2017 Mar; 27(2):97-105. PubMed ID: 27751628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia.
    Cupisti A; D'Alessandro C; Baldi R; Barsotti G
    J Ren Nutr; 2004 Oct; 14(4):220-5. PubMed ID: 15483782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hyperphosphataemia: practices and perspectives amongst the renal care community.
    Nagel CJ; Casal MC; Lindley E; Rogers S; Pancířová J; Kernc J; Copley JB; Fouque D
    J Ren Care; 2014 Dec; 40(4):230-8. PubMed ID: 24814866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 6-Month clinical practice pilot study of sucroferric oxyhydroxide on nutritional status in patients on peritoneal dialysis.
    Perez L; You Z; Teitelbaum I; Andrews ES; Reddin R; Ramirez-Renteria L; Wilson G; Kendrick J
    BMC Nephrol; 2022 Jul; 23(1):245. PubMed ID: 35810296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.
    Kalantar-Zadeh K; Parameswaran V; Ficociello LH; Anderson L; Ofsthun NJ; Kwoh C; Mullon C; Kossmann RJ; Coyne DW
    Am J Nephrol; 2018; 47(3):153-161. PubMed ID: 29514139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control.
    Botelho C; Rodrigues A; Oliveira JC; Cabrita A
    J Nephrol; 2013; 26(1):183-90. PubMed ID: 22460184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Information about phosphorus additives and nutritional counseling].
    Kido S; Nomura K; Sasaki S; Shiozaki Y; Segawa H; Tatsumi S
    Clin Calcium; 2012 Oct; 22(10):1583-91. PubMed ID: 23023640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake.
    Mehrotra R; Supasyndh O; Berman N; Kaysen G; Hurst L; Leonardi M; Das D; Kopple JD
    J Ren Nutr; 2004 Jul; 14(3):134-42. PubMed ID: 15232791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients.
    Shang D; Xie Q; Ge X; Yan H; Tian J; Kuang D; Hao CM; Zhu T
    BMC Nephrol; 2015 Jul; 16():107. PubMed ID: 26187601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most consumed processed foods by patients on hemodialysis: Alert for phosphate-containing additives and the phosphate-to-protein ratio.
    Watanabe MT; Araujo RM; Vogt BP; Barretti P; Caramori JCT
    Clin Nutr ESPEN; 2016 Aug; 14():37-41. PubMed ID: 28531397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.